Intellia Therapeutics, Inc. (NTLA)

NASDAQ: NTLA · Real-Time Price · USD

11.16

-0.95 (-7.84%)

At close: Nov 10, 2026, 4:00 PM EST

11.17

+0.01 (0.09%)

After-hours: Nov 10, 2026, 6:18 PM EST

Intellia Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	52.89	67.67	57.88	36.28	52.12	33.05
Revenue Growth	-8.07%	16.92%	59.55%	-30.40%	57.69%	-43.01%
Cost of Revenue	270.92	324.45	406.91	435.07	419.98	229.81
Gross Profit	-218.03	-256.78	-349.04	-398.79	-367.86	-196.75
Selling, General & Admin	218.81	184.21	185.23	116.5	90.31	71.1
Operating Expenses	218.81	184.21	185.23	116.5	90.31	71.1
Operating Income	-436.85	-440.99	-534.26	-515.29	-458.16	-267.85
Interest & Investment Income	23.32	29.2	47.81	49.83	8.54	1.28
Earnings From Equity Investments	-	-	-	-15.63	-11.08	-1.33
EBT Excluding Unusual Items	-414.14	-411.8	-486.46	-481.09	-460.7	-267.89
Gain (Loss) on Sale of Investments	-14.51	-0.9	-32.57	-	-	-
Other Unusual Items	-	-	-	-0.1	-13.49	-
Pretax Income	-426.14	-412.69	-519.02	-481.19	-474.19	-267.89
Net Income	-426.14	-412.69	-519.02	-481.19	-474.19	-267.89
Net Income to Common	-426.14	-412.69	-519.02	-481.19	-474.19	-267.89
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	127	108	99	89	77	71
Shares Outstanding (Diluted)	127	108	99	89	77	71
Shares Change	21.22%	9.64%	11.35%	15.33%	8.57%	26.63%
EPS (Basic)	-3.35	-3.81	-5.25	-5.42	-6.16	-3.78
EPS (Diluted)	-3.35	-3.81	-5.25	-5.42	-6.16	-3.78
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-358.08	-395.87	-354.66	-408.07	-346.85	-237.79
Free Cash Flow Per Share	-2.82	-3.65	-3.59	-4.60	-4.51	-3.35
Operating Margin	-826.00%	-651.67%	-923.10%	-1420.51%	-879.04%	-810.37%
Profit Margin	-805.75%	-609.85%	-896.77%	-1326.51%	-909.78%	-810.49%
Free Cash Flow Margin	-677.06%	-584.99%	-612.78%	-1124.94%	-665.46%	-719.41%
EBITDA	-428.26	-431.22	-523.98	-506.32	-450.59	-260.96
D&A For EBITDA	8.59	9.77	10.29	8.98	7.57	6.89
EBIT	-436.85	-440.99	-534.26	-515.29	-458.16	-267.85

SEC Filings: 10-K · 10-Q